ROSAH
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients (NCT06395285) | Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm) | 2025-05-27 |
| Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics (NCT00001373) | National Human Genome Research Institute (NHGRI) | 1994-03-10 |
Track ROSAH automatically
Every clearance here is in the API, with alerts when new ones post.